433 related articles for article (PubMed ID: 26856830)
1. In Vitro and In Vivo Trypanosomicidal Action of Novel Arylimidamides against Trypanosoma cruzi.
Guedes-da-Silva FH; Batista DG; Meuser MB; Demarque KC; Fulco TO; Araújo JS; Da Silva PB; Da Silva CF; Patrick DA; Bakunova SM; Bakunov SA; Tidwell RR; Oliveira GM; Britto C; Moreira OC; Soeiro MN
Antimicrob Agents Chemother; 2016 Apr; 60(4):2425-34. PubMed ID: 26856830
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic evaluation and in silico ADMET properties of novel arylimidamides in acute mouse models of
da Silva CF; Batista DDGJ; de Araújo JS; Cunha-Junior EF; Stephens CE; Banerjee M; Farahat AA; Akay S; Fisher MK; Boykin DW; Soeiro MNC
Drug Des Devel Ther; 2017; 11():1095-1105. PubMed ID: 28435221
[TBL] [Abstract][Full Text] [Related]
3. Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease.
García MC; Ponce NE; Sanmarco LM; Manzo RH; Jimenez-Kairuz AF; Aoki MP
Antimicrob Agents Chemother; 2016 Jun; 60(6):3700-8. PubMed ID: 27067322
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo studies of the biological activity of novel arylimidamides against Trypanosoma cruzi.
De Araújo JS; Da Silva CF; Batista DG; Da Silva PB; Meuser MB; Aiub CA; da Silva MF; Araújo-Lima CF; Banerjee M; Farahat AA; Stephens CE; Kumar A; Boykin DW; Soeiro MN
Antimicrob Agents Chemother; 2014 Jul; 58(7):4191-5. PubMed ID: 24590476
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo biological effects of novel arylimidamide derivatives against Trypanosoma cruzi.
Timm BL; da Silva PB; Batista MM; da Silva FH; da Silva CF; Tidwell RR; Patrick DA; Jones SK; Bakunov SA; Bakunova SM; Soeiro Mde N
Antimicrob Agents Chemother; 2014 Jul; 58(7):3720-6. PubMed ID: 24752263
[TBL] [Abstract][Full Text] [Related]
6.
Santos CC; Lionel JR; Peres RB; Batista MM; da Silva PB; de Oliveira GM; da Silva CF; Batista DGJ; Souza SMO; Andrade CH; Neves BJ; Braga RC; Patrick DA; Bakunova SM; Tidwell RR; Soeiro MNC
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203486
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of novel arylimidamides against Trypanosoma cruzi in vitro.
DA Silva CF; Daliry A; DA Silva PB; Akay S; Banerjee M; Farahat AA; Fisher MK; Hu L; Kumar A; Liu Z; Stephens CE; Boykin DW; Correia Soeiro MD
Parasitology; 2011 Dec; 138(14):1863-9. PubMed ID: 21902869
[TBL] [Abstract][Full Text] [Related]
8. Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi.
Santos EC; Novaes RD; Cupertino MC; Bastos DS; Klein RC; Silva EA; Fietto JL; Talvani A; Bahia MT; Oliveira LL
Antimicrob Agents Chemother; 2015 Oct; 59(10):5999-6006. PubMed ID: 26169419
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo drug combination for the treatment of Trypanosoma cruzi infection: A multivariate approach.
Strauss M; Rodrigues JHS; Lo Presti MS; Bazán PC; Báez AL; Paglini-Oliva P; Nakamura CV; Bustamante JM; Rivarola HW
Exp Parasitol; 2018 Jun; 189():19-27. PubMed ID: 29726395
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic Screening In Vitro of Novel Aromatic Amidines against Trypanosoma cruzi.
Simões-Silva MR; Nefertiti AS; De Araújo JS; Batista MM; Da Silva PB; Bahia MT; Menna-Barreto RS; Pavão BP; Green J; Farahat AA; Kumar A; Boykin DW; Soeiro MN
Antimicrob Agents Chemother; 2016 Aug; 60(8):4701-7. PubMed ID: 27216059
[TBL] [Abstract][Full Text] [Related]
11. Anti-parasitic effect of vitamin C alone and in combination with benznidazole against Trypanosoma cruzi.
Puente V; Demaria A; Frank FM; Batlle A; Lombardo ME
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006764. PubMed ID: 30240395
[TBL] [Abstract][Full Text] [Related]
12. Repurposing Strategy of Atorvastatin against Trypanosoma cruzi:
Araujo-Lima CF; Peres RB; Silva PB; Batista MM; Aiub CAF; Felzenszwalb I; Soeiro MNC
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987140
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole.
Torchelsen FKVDS; Silva TM; Milagre MM; Silva RR; Reis LES; Branquinho RT; Silva GN; de Lana M
Parasitol Res; 2021 Apr; 120(4):1511-1517. PubMed ID: 33236174
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease.
Guedes PM; Oliveira FS; Gutierrez FR; da Silva GK; Rodrigues GJ; Bendhack LM; Franco DW; Do Valle Matta MA; Zamboni DS; da Silva RS; Silva JS
Br J Pharmacol; 2010 May; 160(2):270-82. PubMed ID: 20128813
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of essential oil of Syzygium aromaticum alone and in combination with benznidazole on murine oral infection with Trypanosoma cruzi IV.
Zanusso Junior G; Massago M; Kian D; Toledo MJO
Exp Parasitol; 2018 Feb; 185():92-97. PubMed ID: 29305891
[TBL] [Abstract][Full Text] [Related]
16. Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.
Guedes-da-Silva FH; Batista DG; Da Silva CF; De Araújo JS; Pavão BP; Simões-Silva MR; Batista MM; Demarque KC; Moreira OC; Britto C; Lepesheva GI; Soeiro MN
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167559
[TBL] [Abstract][Full Text] [Related]
17. Thioridazine aggravates skeletal myositis, systemic and liver inflammation in Trypanosoma cruzi-infected and benznidazole-treated mice.
Mendonça AAS; Gonçalves-Santos E; Souza-Silva TG; González-Lozano KJ; Caldas IS; Gonçalves RV; Diniz LF; Novaes RD
Int Immunopharmacol; 2020 Aug; 85():106611. PubMed ID: 32447223
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo activity of voriconazole and benznidazole combination on trypanosoma cruzi infection models.
Gulin JEN; Eagleson MA; López-Muñoz RA; Solana ME; Altcheh J; García-Bournissen F
Acta Trop; 2020 Nov; 211():105606. PubMed ID: 32598923
[TBL] [Abstract][Full Text] [Related]
19. Trypanocidal activity and selectivity in vitro of aromatic amidine compounds upon bloodstream and intracellular forms of Trypanosoma cruzi.
De Souza EM; da Silva PB; Nefertiti AS; Ismail MA; Arafa RK; Tao B; Nixon-Smith CK; Boykin DW; Soeiro MN
Exp Parasitol; 2011 Feb; 127(2):429-35. PubMed ID: 20971106
[TBL] [Abstract][Full Text] [Related]
20. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]